Generate Biomedicines, Inc.(GENB)
$13.49-0.29 (-2.10%)
GENB
Generate Biomedicines, Inc. hedge funds
$13.49
At close:-0.29 (-2.10%)
Want to see GENB full AI Analyst Report?
Generate Biomedicines, Inc. (GENB) Hedge Fund Trading Activity
153 Followers
Trend: ▲ Hedge Funds Increased Holdings by 2.4M Shares Last Quarter
Hedge Fund Holdings in GENB
Based on the 13F filings of 489 Hedge Funds tracked by TipRanks, as submitted to the SEC.
Hedge Fund Confidence Signal
Hedge Fund Activity
Activity
Star Ranking
| ARK Investment Management LLC | Added | 157.74% | $21,671,489 | 0.14% | |||
| New | 100.00% | $28,003,626 | <0.01% | ||||
| Flagship Pioneering Inc. | Not Changed | 0.00% | $1,057,295,484 | 68.66% | |||
| Harbourvest Partners Llc | Not Changed | 0.00% | $29,053,683 | 17.09% | |||
| Baker Bros Advisors LP | Not Changed | 0.00% | $24,016,166 | 0.12% |
FAQ
Which hedge funds hold Generate Biomedicines, Inc.?
The hedge funds that hold the most shares in Generate Biomedicines, Inc. are BlackRock, Inc., John Toomey, Jr. and Noubar Afeyan.
Are hedge funds buying or selling GENB?
In the last quarter hedge funds have Increased their holdings in Generate Biomedicines, Inc. by 2.4M shares.
Where can I see a list of the best rated hedge funds?
You can see a list of the best hedge funds here.
Who is the best-performing hedge fund manager?
The top-rated hedge fund managers can be seen here: Top Hedge Fund Managers
Does Warren Buffet hold shares in Generate Biomedicines, Inc. stock?
Warren Buffet currently does not own shares in Generate Biomedicines, Inc..
What is a 13F filing, and how does it help investors?
A 13F form, also known as a "Report of Investment Manager," is a quarterly report that investment advisors registered with the Securities and Exchange Commission (SEC) must file if they manage at least $100 million in assets. The 13F form lists all of the publicly traded securities that the investment advisor owns as of the end of the reporting period. To read more about the 13F, click here

